Sequencing project will map DNA of up to 100,000 patients
A new £100m project will map the DNA of up to 100,000 patients with cancer and other rare diseases.
Dec 11, 2012
0
0
A new £100m project will map the DNA of up to 100,000 patients with cancer and other rare diseases.
Dec 11, 2012
0
0
New Johns Hopkins research showing a more than four-fold increase in the incidence of breast cancer in women with neurofibromatosis-1 (NF1) adds to growing evidence that women with this rare genetic disorder may benefit from ...
Nov 27, 2012
0
1
(Medical Xpress)—During an ice climbing trip to the Canadian Rockies last Christmas, two young researchers from the UW, Michael Schmitt and Jesse Salk, talked about a simple but powerful idea to get better results when ...
Oct 1, 2012
0
0
Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published today by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare.
Sep 28, 2012
0
0
For the first time, a mutation in HIF2α, a specific group of genes known as transcription factors that is involved in red blood cell production and cell metabolism, has been identified in cancer tumor cells.
Sep 6, 2012
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved Afinitor Disperz (everolimus tablets for oral suspension), the first form of the anti-cancer drug Afinitor to be created especially for children.
Aug 29, 2012
0
0
(Medical Xpress)—Scientists at the Medical Research Council (MRC) Laboratory of Molecular Biology have found that stem cells in the body's 'blood cell factory'—the bone marrow—are extremely sensitive to the main breakdown ...
Aug 27, 2012
0
0
A new study of the genetic makeup, or genome, of Ewing sarcoma, a rare cancer that strikes children, teenagers, and young adults, has produced multiple discoveries: a previously unknown sarcoma subtype, genetic factors related ...
Aug 9, 2012
0
0
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Jul 2, 2012
0
0
(Medical Xpress) -- The future of prostate cancer therapy may lie in a tiny, "sticky" silicon chip dubbed GEDI (Geometrically Enhanced Differential Immunocapture, pronounced like the "Star Wars" forces of good) that can identify ...
Jun 28, 2012
0
0